Trials / Recruiting
RecruitingNCT06723197
Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication
Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication: a Multicentre, Randomised, Controlled Trial
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 330 (estimated)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The study aimed to compare the efficacy and safety of dual and quadruple regimens with different durations (7-day, 10-day, 14-day) for the eradication of Helicobacter pylori. Subjects were randomized to receive the intervention and were reviewed by 13C-urea breath test after 6 weeks. The eradication rates, adverse reaction rates and patient adherence were calculated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | vonoprazan+amoxicillin | Drug combinations for dual regimens:vonoprazan+amoxicillin |
| OTHER | Duration of eradication regimen: 7-day | Duration of eradication regimen: 7-day |
| DRUG | vonoprazan+amoxicillin+tetracycline+bismuth | Drug combinations for quadruple regimens: vonoprazan+amoxicillin+tetracycline+bismuth |
| OTHER | Duration of eradication regimen: 10-day | Duration of eradication regimen: 10-day |
| OTHER | Duration of eradication regimen: 14-day | Duration of eradication regimen: 14-day |
Timeline
- Start date
- 2024-12-10
- Primary completion
- 2025-10-01
- Completion
- 2025-11-30
- First posted
- 2024-12-09
- Last updated
- 2024-12-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06723197. Inclusion in this directory is not an endorsement.